Does metabolic syndrome predict significant angiographic coronary artery disease?

Revista Portuguesa de Cardiologia

Volumn 31, Issue 12, 2012, Pages 769-778

  Timot́eo, Ana Teresa ^a   Carmo, Miguel Mota ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Coronary artery disease; Diabetes; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84873406913     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.03.006     Document Type: Article

References (32)

1. Fiúza M, Cortez-Dias N, Martins S, et al. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk - results from the VALSIM study. Rev Port Cardiol. 2008;27:1495-529.
2. Molarius A, Seidell JC, Sans S, et al. Education level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health. 2000;90:1260-8. (Pubitemid 30497380)
3. Garni AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-14. (Pubitemid 46135879)
4. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812-9. (Pubitemid 44415613)
5. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-32.
6. Ertek S, Cicero AF, Cesur M, et al. The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography. Acta Diabetol. 2011;48:21-7.
7. Bayturan O, Tuzcu M, Uno K, et al. Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am J Cardiol. 2010;105:1735-9.
8. Zornitzki T, Ayzenberg O, Gandelman G, et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM. 2007;100:575-81.
9. Anderson J, Horne B, Jones H, et al. Which features of metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease? Cardiology. 2004;101:185-93. (Pubitemid 38314632)
10. Amano T, Matsubara T, Uetani T, et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions. J Am Coll Cardiol. 2007;49:1149-56.
11. Espinola-Klein C, Rupprecht H, Bickel C, et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol. 2007;99:1623-8. (Pubitemid 46874314)
12. Maron DJ, Boden WE, Spertus JA, et al. Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary interventions in the COURAGE trial. J Am Coll Cardiol. 2011;58:131-7.
13. Grundy SM, Cleeman JI, Daniels SR, et al. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
14. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606. (Pubitemid 13187192)
15. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607. (Pubitemid 19004941)
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53. (Pubitemid 28319935)
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment oh High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
18. Alberti K, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-80.
19. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2006;29:S4-42.
20. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
21. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100:1166-73. (Pubitemid 27386301)
22. Onat A, Can G, Hergenc G, et al. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond). 2007;31:1119-25. (Pubitemid 46987762)
23. Hunt KJ, Resendez RG, Williams K, et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004;110:1251-7. (Pubitemid 39202341)
24. Bayturan O, Tuczu EM, Lavoie A, et al. The metabolic syndrome, its component risk factors and progression of coronary atherosclerosis. Arch Intern Med. 2010;170:478-84.
25. Laclaustra M, Ordonez B, Leon M, et al. Metabolic syndrome and coronary heart disease among Spanish male workers: a case-control study of MESYAS. Nutr Metab Cardiovasc Dis. 2012;22:510-6.
26. Kato M, Dote K, Naganuma T, et al. Clinical predictors of culprit plaque rupture assessed on intravascular ultrasound in acute coronary syndromes. Circ J. 2010;74:1936-42.
27. Bayturan O, Tuczu M, Uno K, et al. Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am J Cardiol. 2010;105:1735-9.
28. Blankstein R, Budoff MJ, Shaw LJ, et al. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol. MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:364-74.
29. Oreopoulos A, Padwal R, Norris CM, et al. Effect of obesity on short- and long-term mortality post coronary revascularization: a meta-analysis. Obesity. 2008;16:442-50.
30. Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222-6.
31. O'Connor NJ, Morton JR, Birkmeyer JD, et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Circulation. 1996;93:652-5. (Pubitemid 26052448)
32. Bugiardini R, Merz CB. Angina with "normal" coronary arteries. A changing philosophy. JAMA. 2005;293:477-84.